INVA Q3 2023 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+0.0% YoY

Gross Profit

$57M84.7% margin

Operating Income

$24M36.2% margin

Net Income

$82M122.0% margin

EPS (Diluted)

$0.98

QoQ Revenue Growth

-17.0%

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

$44M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$561M

Stockholders' Equity

$627M

Cash & Equivalents

$180M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$67M	+0.0%
Gross Profit	$57M	$52M	+9.8%
Operating Income	$24M	$12M	+97.4%
Net Income	$82M	$266M	-69.1%

Revenue Segments

Royalty

$54M80%

Product

$14M20%